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Abstract
Barriers to infection act at multiple levels to prevent viruses, bacteria, and parasites from commandeering host cells for their
own purposes. An intriguing hypothesis is that if a cell experiences stress, such as that elicited by inflammation,
endoplasmic reticulum (ER) expansion, or misfolded proteins, then subcellular barriers will be less effective at preventing
viral infection. Here we have used models of cystic fibrosis (CF) to test whether subcellular stress increases susceptibility to
adeno-associated virus (AAV) infection. In human airway epithelium cultured at an air/liquid interface, physiological
conditions of subcellular stress and ER expansion were mimicked using supernatant from mucopurulent material derived
from CF lungs. Using this inflammatory stimulus to recapitulate stress found in diseased airways, we demonstrated that AAV
infection was significantly enhanced. Since over 90% of CF cases are associated with a misfolded variant of Cystic Fibrosis
Transmembrane Conductance Regulator (DF508-CFTR), we then explored whether the presence of misfolded proteins could
independently increase susceptibility to AAV infection. In these models, AAV was an order of magnitude more efficient at
transducing cells expressing DF508-CFTR than in cells expressing wild-type CFTR. Rescue of misfolded DF508-CFTR under
low temperature conditions restored viral transduction efficiency to that demonstrated in controls, suggesting effects
related to protein misfolding were responsible for increasing susceptibility to infection. By testing other CFTR mutants,
G551D, D572N, and 1410X, we have shown this phenomenon is common to other misfolded proteins and not related to loss
of CFTR activity. The presence of misfolded proteins did not affect cell surface attachment of virus or influence expression
levels from promoter transgene cassettes in plasmid transfection studies, indicating exploitation occurs at the level of virion
trafficking or processing. Thus, we surmised that factors enlisted to process misfolded proteins such as DF508-CFTR in the
secretory pathway also act to restrict viral infection. In line with this hypothesis, we found that AAV trafficked to the
microtubule organizing center and localized near Golgi/ER transport proteins. Moreover, AAV infection efficiency could be
modulated with siRNA-mediated knockdown of proteins involved in processing DF508-CFTR or sorting retrograde cargo
from the Golgi and ER (calnexin, KDEL-R, b-COP, and PSMB3). In summary, our data support a model where AAV exploits a
compromised secretory system and, importantly, underscore the gravity with which a stressed subcellular environment,
under internal or external insults, can impact infection efficiency.
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Introduction
Evolutionary biology speaks of ‘survival of the fittest’. A dark
twist to this principle is that often the survival of an organism
depends on its exploitation of another. This relationship is vividly
apparent in virology, as many viruses have evolved as
opportunistic pathogens and take advantage of hosts under
stress. One attractive hypothesis is that this exploitation can occur
at subcellular levels when stresses associated with inflammation,
ER expansion, or misfolded proteins are present. Therefore, in
this study we have explored whether pleiotropic subcellular
stressors and effects related to misfolded protein processing
will mitigate barriers to infection using models of cystic fibrosis
(CF).
CF is the most common lethal progressive hereditary disorder in
Caucasian populations [1] and manifests primarily in the lungs.
Afflicted individuals are plagued by mucus accumulation, airway
inflammation, and persistent infections. This monogenic disorder
PLoS Pathogens | www.plospathogens.org 1 May 2011 | Volume 7 | Issue 5 | e1002053is typically linked to mutations in the Cystic Fibrosis Transmem-
brane Conductance Regulator (CFTR). CFTR is a cyclic
adenosine monophosphate-activated chloride ion channel that
primarily functions at the apical surface of airway epithelium. Loss
of normal CFTR function impairs regulation of chloride transport
across the airway surface, which leads to a reduction of airway
surface liquid volume, airway mucus dehydration, decreased
mucus transport, and increased risk of airway infection.
A single deletion of a phenylalanine residue at position 508 in
CFTR (DF508-CFTR) results in a misfolded protein that is
associated with approximately 90% of CF cases [2]. The DF508
mutation disrupts the proper folding of CFTR during transit in the
cellular secretory pathway, thus incorrectly limiting its glycosyla-
tion and trafficking to the plasma membrane. When the secretory
pathway identifies DF508-CFTR as misfolded it is rapidly
degraded in the cell through ER-associated degradation [3,4].
Historically, degradation of misfolded CFTR was thought to occur
primarily via ubiquitin-proteasome degradation pathways [5,6],
but recent evidence suggests autophagy may also play a role [7].
While controversy exists over whether effects related to DF508-
CFTR misfolding play a role in disease progression, it has been
clearly documented that CF cells experience subcellular stress as
indicated by increased sensitivity to Ca
2+-mediated inflammation,
ER-expansion, and activation of the unfolded protein response
[8,9]. Independent of an exogenous inflammatory stimulus,
overexpression of DF508-CFTR in vitro causes ER stress, activates
an unfolded protein response [10], and is a well-established model
for studying subcellular effects of the misfolded protein [11].
Misfolded proteins and pathogens that rely on cellular machinery
for their life-cycles use a common trafficking pathway that sorts
them to the microtubule organizing center (MTOC) where they can
be targeted for degradation by either the ubiquitin/proteasome
system or the autophagosome/lysosome [12,13,14]. Also known as
the centrosome, the MTOC is the point of origin from which
microtubules emanate outward toward the cell periphery. This
network of microtubules provides a scaffold for the organization of
key vesicles and organelles such as endosomes, lysosomes, the Golgi
apparatus, and the nucleus [15]. Retrograde trafficking along
microtubules may be beneficial to viruses during entry, as it has the
potential to place the infectious material in close proximity to the
nucleus. However, the high concentration of proteasomes and
lysosomes in this region [16,17] may serve to expedite degradation
and clearance of pathogen components from the cell; thus,
restricting infection. During subcellular stress, the degradation
and sorting capacity at the MTOC can be exceeded, which can
result in proteasome dysfunction, accumulation of protein aggre-
gates, formation of aggresomes, expansion of the secretory pathway,
and activationof the unfolded protein response [18]. Based on these
findings, we hypothesized that cells under stress due to misfolded
proteins might be more susceptible to virus infection.
For these studies we tested if subcellular stress and expression of
misfolded proteins could be exploited by adeno-associated virus
(AAV) and promote increased infection efficiency. AAV is a non-
enveloped parvovirus and classified as a dependovirus, as it will only
enter a replicative state when specific conditions are obtained in
the host cell, such as during coinfection with a helper virus like
adenovirus or herpes virus [19]. It has previously been shown that
the most highly characterized serotype, AAV2, is inefficient at
delivering its genome to the nucleus, with the majority of virions
remaining outside the nuclear membrane [20,21,22]. After cell
surface binding, AAV2 infection progresses through clathrin- and
dynamin-dependent internalization into an endosomal compart-
ment [23,24,25]. Capsids have been detected in the early
endosome, recycling endosome, late endosome, lysosome, and
Golgi apparatus [26]. Although many details of AAV infection
remain to be elucidated, it represents an attractive virus for testing
our hypothesis since AAV2 undergoes retrograde trafficking on
microtubules [27] and infection is negatively affected by the
ubiquitin/proteasome system [28]. Indeed, it has been shown that
proteasome inhibitors potentiate AAV-mediated gene delivery by
up to several hundred fold [21,22,28,29]. Therefore, it seems likely
that AAV virions may be handled in a manner similar to misfolded
proteins, and following pharmacological interference or saturation
of these pathways, the cell would be less equipped to block virus
trafficking and be rendered more susceptible to infection.
Here, we demonstrate that cells under subcellular stress are more
susceptible to viral infection. Cells expressing DF508-CFTR were
more susceptible to AAV transduction by an order of magnitude
over cells expressing wild-type CFTR. This effect was not due to
differences in AAV cell-surface attachment or changes in reporter
gene expression, since no significant variation was observed in virus
binding studies or in expression levels of plasmid reporters from
transfection studies. Our results suggest that the exploitation of
cellular entry by AAV is at the level of virus trafficking or capsid
processing through a direct or indirect relationship with compo-
nents of the secretory pathway. These findings connect stresses
associated with misfolded proteins and the secretory system to
diminishing subcellular barriers to infection.
Results
Human ciliated airway epithelial cell (HAE) cultures under
subcellular stress are rendered more susceptible to AAV
infection
It has previously been demonstrated that the subcellular status
of the CF airway epithelium displays an increase in sensitivity to
Ca
2+-mediated inflammation, expansion of the ER, and
activation of the unfolded protein response [8,9,30]. These
conditions can be reproduced in HAE cultures derived from
excised lung tissue by apical administration of an inflammatory
stimulus; supernatant from mucopurulent material (SMM) [8,9],
derived from CF airways. We used SMM to model the
Author Summary
Misfolded proteins have been associated with a variety of
disorders such as cystic fibrosis, diabetes insipidus, alpha-
antitrypsin deficiency, Parkinson’s disease, and cancer. In
this study, by using cellular models of events in cystic
fibrosis lung disease we have revealed an effect of
misfolded proteins on increasing susceptibility to infection
with a parvovirus. Infection efficiency was an order of
magnitude higher in cells expressing misfolded Cystic
Fibrosis Transmembrane Conductance Regulator (CFTR)
mutant proteins than in cells expressing the correctly
folded protein. During infection, virus capsids accumulated
near cellular factors that normally process misfolded
proteins and are involved in retrograde trafficking from
the Golgi to endoplasmic reticulum. Furthermore, we have
demonstrated thatinfectionefficiencycanbeattenuated by
restoring correct protein folding or augmented by siRNA-
mediated knockdown of secretory pathway components.
Taken together our results indicate that converging cellular
systems operate to clear misfolded proteins and virus
capsids from an infected cell. We raise the possibility that
parvoviruses and perhaps other viruses exploit congested
cellular secretory pathways during entry, and that viral
infection could be a contributing factor in the progression
of diseases associated with misfolded proteins.
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these conditions increase the susceptibility of HAE to AAV
transduction. SMM or a PBS control was applied to the apical
surface of HAE grown at an air-liquid interface. After 24 hrs of
SMM treatment, HAE cultures were inoculated at the apical
surface with an AAV variant (HAE-2), carrying transgene
reporters for either enhanced green fluorescent protein (GFP) or
firefly luciferase (Luc), that we have previously generated by
molecular directed evolution [31]. As described by Li et al.,
transduction could be detected by one week post-inoculation
[31], although we found significantly more GFP-positive cells in
HAE treated with SMM prior to AAV inoculation (Fig. 1A,
panels iv, v, and vi), compared to controls (panels i, ii, and iii).
Quantification in parallel cultures using AAV expressing
luciferase showed that although the difference in luciferase
activity between cultures treated with PBS or SMM was not as
great as that for GFP, transduction in SMM-treated samples was
2-fold higher than controls (Fig. 1B) and found to be statistically
significant (p-value,0.05). For the remainder of these studies we
have employed use of the prototypic serotype, AAV2, which has
been more thoroughly characterized than the variant, HAE-2.
Since it is difficult to detect transduction of AAV2 in airway
epithelium cultures, for this experiment it was more appropriate
to utilize the AAV variant that exhibits the capacity for greater
transduction in these cells.
Cells expressing DF508 CFTR are more permissive to viral
infection
Using an inflammatory stimulant to induce subcellular stress in
HAE cultures has pluripotent consequences that may affect
changes in addition to expansion of the secretory pathway and
activation of the unfolded protein response. Since the majority of
CF disease is associated with misfolded DF508-CFTR [2], we
sought to explore whether expression of misfolded proteins could
independently increase infection efficiency of AAV2 or other
human respiratory viruses. To this end, stable lines of control
wild-type BHK-21 cells, BHK-21 cells overexpressing CFTR, or
BHK-21 cells overexpressing DF508-CFTR, were inoculated
with self-complementary AAV2 (scAAV2), adenovirus (Ad), or
respiratory syncytial virus (RSV) packaging GFP reporter genes
(Fig. 2). Transduction was noticeably higher for all three viruses
in cells expressing DF508-CFTR. We chose to continue our
analysis of this exploitation of misfolded DF508-CFTR using
AAV as a model opportunistic respiratory virus. Similar to what
was observed for scAAV2, 24 hr after inoculation of single-
stranded rAAV2, the expression of GFP (Fig. 3A) or Luc (Fig. 3B)
reporters indicated that infection was significantly more efficient
in DF508-CFTR-expressing cells than in control or CFTR-
overexpressing BHK-21 cells. Similar data to that shown for
BHK-21 cells was also obtained in other cell lines such as CHO
and HEK-293, with higher AAV2 transduction efficiencies
measured in DF508-CFTR-expressing cells as compared to
controls (wild-type BHK-21 cells or CFTR-expressing cells, data
not shown).
Luciferase assays suggested that AAV transduction efficiency
was augmented 10-fold in cells expressing DF508-CFTR over
controls, yet it is difficult to determine from this approach alone
whether the enhanced efficiency stems from an increase in the
number of cells transduced or an increase in expression intensity.
To more clearly assess this enhancement, we analyzed cells
inoculated with AAV-GFP by flow cytometry. GFP expression
levels were similar at low virion numbers [100 vector genomes per
Figure 1. Human airway epithelium under stress is more susceptible to AAV infection. HAE cultures were exposed to SMM an
inflammatory stimulant derived from CF airways by application to the apical surface to induce cellular stress and model diseased airway. 24 hr after
application, SMM was removed and HAE infected with an AAV variant generated by molecular directed evolution. A. Representative en face images of
three HAE cultures one week after inoculation with AAV packaging an eGFP transgene, showing GFP positive cells (green) in HAE cultures exposed to
PBS (panels i, ii, and iii) or SMM (iv, v, and vi). B. Parallel experiments performed on HAE cultures with an AAV packaging a Luc transgene. Cells were
harvested one week after inoculation and luciferase activity was assessed. Error bars represent standard deviations from three separate inoculations.
Data shown are representative from three independent experiments (* p-value,0.05).
doi:10.1371/journal.ppat.1002053.g001
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values acquired from GFP-positive cells (Fig. 3C). Thus,
transcription, translation, and transgene expression levels from
one infectious event likely did not differ much between control,
CFTR, and DF508-CFTR cells. At higher virion numbers, GFP
expression levels per cell were significantly higher in DF508 cells
(Fig. 3C), suggesting the threshold for multiple infectious events is
lower in cells expressing the misfolded protein. Consistent with this
finding, we determined that the number of GFP-positive cells was
greater in DF508-CFTR cells than in controls (Fig. 3D); [AAV2-
GFP (1000 vg/cell) transduced 48.4%60.8% of DF508-CFTR
cells, compared to 13.8%60.8% and 15.7%60.3%, of control
and CFTR cells, respectively]. This improvement in the number
of cells transduced by AAV was similar over a range of particle
numbers, from 100 vg/cell to 10000 vg/cell and was observed for
two different promoters: TR-CMV-GFP and TR-CBA-GFP (data
not shown).
Effect of low temperature on processing of DF508-CFTR
and transduction by AAV
DF508-CFTR folding and trafficking defects can be rescued by
culturing cells under low temperature (27uC) conditions [32,33].
If the repercussions from processing misfolded proteins benefits
viral infection, then reducing the misfolded protein burden by
low temperature conditioning should mitigate the infectious
advantage observed in DF508-CFTR cells. To test this notion, we
assayed AAV infection under low temperature conditions in
control BHK-21 cells and cells overexpressing CFTR or DF508-
CFTR after 48 hrs of maintaining the cells at 27uCo r3 7 uC. We
first determined whether our protocol resulted in corrected
trafficking of DF508-CFTR by performing western blot analysis.
Figure 4A shows that after two days of low-temperature
conditioning at 27uC, a considerable amount of DF508-CFTR
protein is correctly glycosylated and runs at the predicted
molecular mass (,180 kD) indicating a rescued phenotype
similar to wild-type CFTR. We noted that overall levels of
infection efficiency at 27uC are below what is observed at 37uC
(compare Fig. 4B with Fig. 3B). Nonetheless, we observed AAV2
transduction efficiency to be at least 3-fold higher in DF508-
CFTR cells than in control cells and CFTR cells (Fig. 4B, white
columns) when these cells were initially held at 37uC. In contrast,
after preconditioning cells at 27uC, we observed no differences in
AAV2 transduction levels between control, CFTR, and DF508-
CFTR cells (Fig. 4B, black columns), suggesting that enhanced
Figure 2. Cells expressing misfolded DF508-CFTR are more permissive to infection with human respiratory viruses. Images of GFP-
positive cells after inoculation with recombinant self-complementary AAV (scAAV2, 100 vg/cell: eGFP transgene), adenovirus (Ad; 20 vg/cell), or
respiratory syncytial virus (RSV; 200 vg/cell) into control BHK-21 cells (panel i), BHK-21 cells overexpressing CFTR (ii), or BHK-21 cells overexpressing
DF508-CFTR (iii). Representative phase contrast images are shown to demonstrate equivalent levels of confluence.
doi:10.1371/journal.ppat.1002053.g002
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PLoS Pathogens | www.plospathogens.org 4 May 2011 | Volume 7 | Issue 5 | e1002053Figure 3. Cells expressing misfolded DF508-CFTR are more permissive to AAV infection. A. Images of GFP-positive cells after
administration of recombinant AAV (AAV2, 1,000 vg/cell: eGFP transgene) to BHK-21 cells (panel i), BHK-21 cells overexpressing CFTR (ii), or BHK-21
cells overexpressing DF508-CFTR (iii). B. Luciferase activity of cells after transduction by AAV (AAV2, 1,000 vg/cell: Luc transgene) in control BHK-21
cells, or cells expressing CFTR, or expressing DF508-CFTR. C. Flow cytometry analysis of AAV transduction at increasing particle numbers showing
mean fluorescence intensity (MFI) of GFP expression from positive cells after inoculation with AAV2-GFP at 100, 1000, or 10000 vg/cell. D. Plots show
percent of GFP-positive cells after infection with AAV2-GFP (1,000 vg/cell) in control BHK-21 cells, CFTR cells, or DF508-CFTR cells. Samples that were
statistically different from controls are marked (*p,0.05; **p,0.01).
doi:10.1371/journal.ppat.1002053.g003
Figure 4. Effect of low temperature conditioning or expression of other misfolded proteins on AAV2 infection. A. Western blot
showing immature form of CFTR and DF508 (black arrow) and mature glycosylated form (arrowhead). Following low temperature conditioning (2 d,
27uC), a significant amount of DF508-CFTR becomes more complexly glycosylated. Asterisks (*) represent non-specific banding and demonstrate
equal loading. B. Luciferase assay of transduction after low temp conditioning, and a comparative control at 27uC. Cells were infected with AAV2
(10,000 vg/cell) as indicated and luciferase activity was measured 24 hr later. C. Comparative analysis of mutant CFTR processing with AAV2
transduction. Western blot of proteins expressed in BHK-21 cell lines depicting level of glycosylation of CFTR, and mutants DF508 (misfolded), G551D
(properly folded), D572N (misfolded), 14106(intermediate folding defect). Related ABC transporter proteins MRP1 and an analogous mutant DF728-
MRP1 are also shown. D. Luciferase assay for transduction in these cell lines following administration of AAV2 (10,000 vg/cell). Samples that were
statistically different from controls are indicated with p-values marked (*p,0.05; **p,0.01).
doi:10.1371/journal.ppat.1002053.g004
AAV Exploits Subcellular Stress during Entry
PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002053transduction efficiency in DF508-expressing cells was lost once
the protein was allowed to fold correctly and traffic to the cell
membrane.
Comparative analysis of mutant CFTR processing with
AAV2 transduction
In addition to performing DF508-CFTR rescue experiments, we
explored whether increased infection efficiency in the presence of
DF508-CFTR was a generalized phenomenon that could be
reproduced with other misfolded proteins. To this end, we tested
AAV transduction efficiency in BHK-21 cells lines expressing
CFTR or DF508-CFTR compared to cell lines expressing other
mutant CFTR proteins and related ABC transporters. The
G551D (glycine to aspartic acid) CFTR mutant folds properly
and traffics to the plasma membrane, but does not display an
operative chloride ion channel [34]. When AAV2 was adminis-
tered to cell lines expressing G551D-CFTR (Fig. 4C), no
significant difference in transduction was observed compared to
control or CFTR-expressing cells (Fig. 4D). We also tested two
other CFTR mutants that, like DF508-CFTR, do not traffic to the
membrane (Fig. 4C). D572N (aspartic acid to asparagine) CFTR is
misfolded, rapidly cleared from the cell, and cannot be rescued
even at low temperature, whereas the truncated 1410X-CFTR
mutant shows a partial defect in trafficking [35]. Based on
measured levels of transduction, AAV is able to exploit expression
of D572N-CFTR to levels similar to that achieved in DF508-
CFTR-expressing cells. However, the effect of 1410X-CFTR
expression on AAV transduction was intermediate between that
measured in DF508-CFTR and control cells. It is interesting to
note that the level of transduction enhancement corresponded to
the degree of misfolding for each of the CFTR mutants, as
indicated by the ratio of immature (mass) to mature (mass)
glycosylated forms of protein (Fig. 4C). Related ABC transporter
proteins MRP1 and an analogous mutant to DF508-CFTR
(DF728-MRP1) do not share the misfolding and degradation
pattern of DF508-CFTR [36] and when expressed in BHK-21
cells do not render cells more susceptible to AAV2 transduction.
Together, these data suggest that AAV is able to exploit cells
expressing a variety of misfolded proteins. Moreover, this
exploitation is not related to loss of wild-type CFTR activity at
the plasma membrane, since G551D-CFTR-expressing cells did
not show increased AAV transduction even in the absence of ion
channel function.
Cell-surface attachment of AAV to control, CFTR, and
DF508-CFTR expressing cells is similar
Virions could potentially take advantage of cells under stress at a
number of steps in the infectious pathway. To test whether
expression of misfolded DF508 CFTR renders cells more
susceptible to infection due to an increase in cell surface
attachment of virus particles, we performed a binding assay with
AAV2 on these cell lines (supplementary Fig. S1A). Equal numbers
of control wild-type BHK-21 cells (purple diamonds), cells
expressing CFTR (red squares), or DF508-CFTR (blue triangles)
cooled to 4uC in order to inhibit endocytosis. While at this
temperature, AAV2 virions were administered to the cell medium
(10,000 vg/cell) for 5, 10, 20, or 60 min. Subsequently, unbound
virus particles and medium were washed from the cells and the
remaining cell-associated vector genomes were isolated by DNA
purification. Vector genome amounts were quantified by qPCR
and no significant differences were observed in binding rates,
indicating that AAV2 likely exploits expression of DF508-CFTR at
steps in the infectious pathway after cellular attachment.
Analysis of expression levels after transfection of reporter
plasmids
To determine whether DF508-CFTR expression influenced
transcription, translation, or reporter protein stability, we
exogenously introduced GFP or Luc reporter plasmids into
wild-type BHK-21 cells or cells expressing CFTR or DF508-
CFTR by transfection and quantified expression levels by flow
cytometry and luciferase assay 24 hr later. It should be noted
these were the same promoter-transgene cassettes that were used
for virus production. Expression of GFP after transfection was
within the same order of magnitude among control cells, cells
expressing CFTR, or cells expressing DF508 (supplementary Fig.
S1B). Results from luciferase assays were similar to those from
flow cytometry, (supplementary Fig. S1C). Transfection of
reporter plasmids into CFTR-expressing cells yielded higher
GFP and Luc expression intensities, and transfection into DF508-
expressing cells resulting in slightly lower reporter gene
expression levels than those seen with CFTR. In the GFP
study, but not for Luc, these differences were found to have a
p-value of less than 0.01, yet in both cases the differences were
less than two-fold. While not dramatically different, the
observation that general expression levels after transfection
were higher in CFTR-expressing cells than in DF508 cells
might imply a further distinction in how significantly DF508 cells
are more susceptible to viral transduction. From these experi-
ments it is reasonable to conclude that AAV virions are able to
exploit cells expressing misfolded DF508-CFTR at steps after
receptor binding but prior to vector gene expression during
infection.
Localization of AAV capsids in control, CFTR, or DF508-
CFTR cells
To explore the possibility that DF508-CFTR has an
observable effect on the trafficking profiles of AAV2 capsids,
we followed AAV trafficking by confocal immunofluorescence
microscopy during infection. In BHK-21 cells, at no time point
after inoculation was there a clear distinction between
localization of capsids (green) in control cells, CFTR cells, and
DF508-expressing cells (16 hr time point shown, Fig. 5A). BHK-
21 cells that were not infected with virus were processed
identically to other samples and demonstrate no background
antibody staining (Fig. 5A, panel i). Capsid staining displayed
the characteristic perinuclear ring in all cell types, with various
amounts of punctate or aggregated capsid signal surrounding the
nucleus (blue). At this level of resolution there did not appear to
be a significant difference in capsid trafficking among these
cell types, but the possibility remains that capsids could be
processed differently in DF508-CFTR cells, which could result in
more efficient or expedited delivery of the transgene to the
nucleus.
Mutant DF508-CFTR is usually recognized by quality control
proteins in the secretory pathway as being misfolded and is
extracted into the cytoplasm and subject to ER-associated
degradation through the ubiquitin/proteasome system [37].
With this in mind, we analyzed z-stacked confocal slices of
viral infection utilizing 3D volume-rendering software to
determine if AAV2 virions colocalized with wild-type CFTR
(Fig. 5B, panel ii, red) or DF508-CFTR (panel iii, red) in BHK-
21 cells. We did not detect any obvious colocalization between
capsids and wild-type CFTR or DF508-CFTR, although we
could not rule out the possibility that components of their
trafficking pathways converge upstream of their degradation at a
separate subcellular location.
AAV Exploits Subcellular Stress during Entry
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cellular markers
Two major cellular compartments arranged in a perinuclear
fashion are the Golgi apparatus and ER, which are oriented
towards the MTOC. AAV serotypes have previously been
reported to associate with the Golgi during infection, although
the significance of this association is not yet understood, [23,38].
To date, AAV has not been shown to enter the ER, but other
viruses such as SV40 will engage retrograde transport pathways
from endocytic compartments to the ER, undergo disulfide
processing in the ER, and then translocate into the cytosol in
order for subsequent steps in infection to proceed [39,40,41]. It is
not clear if AAV requires processing in either the ER or Golgi
during infection, but a preponderance of capsids are found to
accumulate perinuclearly. With this in mind, we asked whether
we could detect capsids in the secretory pathway near well
characterized markers of the ER, Golgi, and factors that route
cargo between these compartments. We have previously estab-
lished that perinuclear accumulation of capsids occurs early after
infection and peaks in intensity around 16 hr post inoculation
[42] in HeLa cells. Therefore, we inoculated HeLa cells with
AAV2 and prepped samples for confocal immunofluorescence
16 hr later with antibodies directed toward cellular markers (red)
for ER-resident chaperones (BiP, calnexin, calreticulin), Golgi
sorting components (b-COP, KDEL-R), or AAV2 capsids (green)
(Fig. 6). No obvious colocalization was found between AAV
capsids and traditional markers for the ER, BiP/Grp78, calnexin,
or calreticulin [43]. Although fluorescent signal corresponding to
capsids emanated from the same area of the cell as BiP, calnexin,
or calreticulin, these signals predominantly did not overlay with
one another. Moderate colocalization was detected between
AAV2 and KDEL-R, a receptor that recognizes lysine-aspartate-
glutamate-arginine (KDEL) lumenal signal sequences at the C-
terminus of proteins [44,45,46]. KDEL-R serves as an ER-
retention device for misfolded proteins and transitions between
the Golgi and the ER [44]. We detected significant colocalization
with b-COP (Fig. 6), a component of the coatomer complex that
is typically associated with COPI transport in retrograde
direction from the Golgi to the ER [47]. While we and others
have previously demonstrated that rAAV capsids colocalize with
Figure 5. Perinuclear accumulation of AAV capsids in control, CFTR, or DF508-CFTR cells. A. Confocal immunofluorescence staining of
capsids (green) 16 hr post-inoculation (50,000 vg/cell) do not demonstrate obvious differences in subcellular trafficking at this level of resolution. B.
Single cell 3D composites were rendered using volume imaging software on z-stacked images taken after co-staining virus capsids with CFTR (panel
ii, red) or DF508-CFTR (iii, red). Absence of yellow color suggests no direct interaction between AAV and wt or mutant CFTR, yet does not rule out that
they could be degraded or processed through the same pathway. Nuclei (blue) were stained with DAPI.
doi:10.1371/journal.ppat.1002053.g005
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here indicate that capsids may also route through other structures
in the post-ER secretory system. KDEL-R and b-COP are also
known to sort proteins through the ER-Golgi intermediate
compartment, but we did not observe significant capsid
colocalization with a marker for this compartment, ERGIC-53
(data not shown), which is consistent with reports stating that
ERGIC-53 is more well-represented in the ER than either
KDEL-R or b-COP [49]. While we did not find substantial
evidence of AAV2 colocalization with the ER, the partial
colocalization between AAV2 and KDEL-R or b-COP (Fig. 6,
white arrows) supports the notion that an AAV2 capsid
population traffics through the Golgi apparatus and might be
further routed through the secretory pathway in a retrograde
direction.
siRNA-mediated knockdown of secretory pathway
components influences AAV infection efficiency
Using microscopy methods alone, it is difficult to determine
whether sorting of capsids through the secretory pathway is a
necessary step during infection. Several studies including this
one, have used physical or pharmacological stressors that
perturb secretory system traffic to enhance AAV transduction
(supplementary Fig. S2), but these agents have a multitude of
other cellular effects [28,50,51,52]. To test if knockdown of
specific components could positively or negatively impact AAV
infection, we employed siRNA-mediated knockdown of proteins
involved in ER quality control (BiP, calnexin, calreticulin),
proteins involved in retrograde transport (KDEL-R, b-COP),
proteins required for aggresomes formation and autophagy
(HDAC6, dynactin), and proteasome subunit beta type-3
(PSMB3). HEK-293 cells (Fig. 7, A & C) or HeLa cells (Fig. 7,
B & D) were mock transfected or transfected with non-targeted
control siRNA, or siRNAs directed toward the aforementioned
targets. Specific knockdown for each target was verified two days
after transfection by western analysis of protein levels or by
quantifying cellular mRNA levels compared to controls (supple-
mentary Fig. S3). After knockdown, cells were replated at equal
densities, inoculated with AAV2-GFP, and fixed for flow
cytometry 24 hr post-inoculation. Under these conditions, no
significant difference in either percentage of cells infected (%
GFP positive, Fig. 7A & B) or mean fluorescence intensity (MFI,
C & D) was observed between samples treated with mock
conditions, control siRNA, BiP siRNA, calreticulin siRNA,
HDAC6 siRNA, or dynactin siRNA. Notably, siRNA-mediated
knockdown of calnexin increased the percentage of cells infected
with AAV-GFP in both HEK-293 and HeLa cells. Knockdown
of KDEL-R increased the number of GFP-positive HeLa cells
and augmented expression intensity (Fig. 7, B & D), and we
found a similar effect on the number of cells transduced in
HEK-293 samples (Fig. 7A). Interestingly, we observed cell-type
specific effects from knockdown of b-COP, which resulted in a
modest increase of AAV transduction in HEK-293 cells, but in
contrast, led to a significant decrease (more than 5-fold) in the
percentage of transduced HeLa cells. With respect to the
negative effect of b-COP siRNA on AAV transduction in HeLa
cells, this outcome may simply be due to a reduction in cell
viability or global disruption of secretory pathway traffic, as
previously reported [53]. Cells transduced with a lenti-GFP
control vector, did not display significant differences in MFIs
Figure 6. AAV capsids traffic to locations near Golgi/ER transport components. AAV2 virions (10,000 vg/cell) were administered to HeLa
cells for 16 hr and prepped for confocal immunofluorescence with antibodies directed toward cellular markers (red) for ER-resident chaperones (BiP,
calnexin, calreticulin), Golgi sorting components (KDEL-R,b-COP), or AAV2 capsids (green). Nuclei (blue) were stained with DAPI. White arrows indicate
partial colocalization with KDEL-R and b-COP, yet it is difficult to assess whether colocalization occurs with ER markers.
doi:10.1371/journal.ppat.1002053.g006
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empty columns), ruling out aberrant effects on reporter gene
expression.
Additionally, knockdown of PSMB3 significantly increased the
percentage of GFP-positive cells transduced by AAV, and had a
dramatic effect on MFI for both HEK-293 and HeLa cell types.
Since PSMB3 is a part of the 20S core of the proteasome, this
finding is consistent with the notion that the ubiquitin/proteasome
system plays a role to restrict AAV infection. As functional
evidence for this effect, siRNA targeting PSMB3, but not other
secretory pathway components, reduced catalytic activity of the
proteasome (supplementary Fig. S4). We also noted that
knockdown of PSMB3 increased the number of GFP-positive
cells transduced by lenti-GFP, in accord with previous lentiviral
studies with proteasome inhibitors [54,55], which supports the
hypothesis that the proteasome system is involved in restricting
entry or processing of viruses from more than one class.
The siRNA-mediated effects on AAV transduction were not due
to an indirect effect on virus uptake, as similar numbers of vector
genomes were present in cells after infection as measured by qPCR
(supplementary Fig. S5). Additionally, the same modulated
patterns of transduction in siRNA-treated HEK-293 and HeLa
cells were found for self-complementary AAV2 (supplementary
Fig. S6), ruling out the possibility that increased transduction
resulted from increased efficiency of second-strand synthesis. We
have demonstrated that infection efficiency can be significantly
affected by ablating proteins involved in sorting or degradation:
calnexin, KDEL-R, b-COP, or PSMB3. Results from our studies
suggest that a population of AAV virions is routed through the
post-ER secretory pathway during entry, and these virions
experience an infectious advantage when this pathway is
compromised.
Discussion
These studies describe how subcellular stress increases suscep-
tibility to infection with the parvovirus, AAV, in cellular models of
CF. We report that AAV infection efficiency is significantly higher
Figure 7. Knockdown of secretory pathway components or proteins involved in CFTR processing impacts AAV infection.
Transduction efficiency of AAV following siRNA-mediated knockdown of proteins in HEK-293 cells (A & C) or HeLa cells (B & D). A margin of error for
nonsignificant perturbations of infection (roughly 630% relative to controls) is indicated by dashed lines. Cells were mock transfected or transfected
with non-targeting control siRNA, or siRNA targeting BiP, calnexin, calreticulin, KDEL-R, b-COP, HDAC6, dynactin, or PSMB3. Between 36 and 48 hr
after transfection, cells were infected with AAV2-GFP (200 vg/cell, HEK-293; 500 vg/cell HeLa) and fixed for flow cytometry 24 hr post-infection. Data
is reported as the percentage of cells infected (% GFP positive, A & B) or mean fluorescence intensity (MFI, C & D) from cells that are positive.
Differences in cell-type specificity are apparent with b-COP, but ultimately these results suggest AAV infection can be influenced by components of
the secretory pathway and the proteasome. Cells infected with lenti-GFP as a control, do not display significant differences in MFI (C & D, black
columns), ruling out aberrant effects on reporter gene expression. Error bars represent standard deviation and graphs are representative data sets of
at least three independent experiments. Samples that were statistically different from controls are marked (*p,0.05; **p,0.01).
doi:10.1371/journal.ppat.1002053.g007
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an inflammatory stimulant derived from diseased lungs that
models physiological conditions present in CF airways. Granting
that SMM is a pleiotropic model of subcellular stress, we
demonstrate independently that expression of misfolded DF508-
CFTR is sufficient to increase infection efficiency by 5- to 10-fold
(Figs. 3 & 4). A similar opportunistic phenomenon also occurs with
the human respiratory pathogens, Ad and RSV (Fig. 2), which are
known to have a disproportionately greater impact on CF patients
than on normal individuals [56,57]. Although it remains to be seen
if the same mechanisms are responsible for enhancing virus
infection in all cases, effects related to protein misfolding were
primary factors involved in the increased susceptibility to AAV.
Rescuing misfolded DF508-CFTR with low temperature condi-
tioning blocked the elevation in rAAV2 infection efficiency.
Additionally, using a panel of mutant CFTR proteins we show this
phenomenon is common to other misfolded proteins and not
related to loss of CFTR activity, since the G551D-CFTR mutant
did not confer increased susceptibility to AAV infection. While we
did not find direct colocalization between AAV and CFTR
proteins, we were able to detect virus capsids in regions of the
secretory pathway that correspond to retrograde trafficking out of
the Golgi apparatus. Furthermore, we have demonstrated that
infection efficiency can be modulated by siRNA-mediated
knockdown of components in the secretory pathway or the
proteasome. With this work we have provided evidence that
factors in the secretory pathway are enlisted to process misfolded
proteins and protect against infection.
Manipulation and subversion of stress responses is a common
thread in virus replication. Hepatitis B virus is known to activate
an ER stress response in order to optimize production of its surface
proteins [58]. Japanese encephalitis virus infection similarly
triggers ER stress and activates an unfolded protein response,
thus promoting apoptosis and progeny dissemination [59]. Other
viruses, such as human cytomegalovirus and herpes viruses, have
evolved mechanisms that activate chaperone upregulation and
expand the ER, while controlling unwanted consequences of
eIF2a phosphorylation, which would normally inhibit protein
translation [60,61]. In our studies, the AAV reporter virus has
been stripped of its wild-type viral genome and does not replicate.
Taken together with the fact that no difference was observed in
DF508-CFTR-expressing cells with respect to virus binding, and
the effect on transduction was not observed in promoter transgene
cassette transfection studies (supplementary Fig. S1), our focus
became more narrowed toward studying how exploitation of
subcellular stress may occur during virus entry.
A variety of drug treatments and physical stressors are known
to increase infection efficiency of AAV through effects on capsid
processing or genome amplification [28,50,51,52]. It should be
noted that AAV capsids are trafficked to the MTOC early during
infection (supplementary Fig. S2A), a location where misfolded
proteins are targeted for degradation [62]. Typically, select
cytoplasmic proteins are marked for degradation by ubiquitin, a
signaling hallmark that can direct either a change in substrate
trafficking or promote substrate degradation via the proteasome.
Previous research has demonstrated AAV serotypes -2 and -5 can
be ubiquitinated during in vitro reactions and during infection
[63]. Likewise, pharmacological inhibition of the proteasome
results in a potent increase in AAV infection efficiency in a cell-
and serotype-specific manner [28,64], although the mechanisms
responsible are not completely understood. This prompts the
question of whether enhanced infection of DF508-CFTR cells is
due to proteasome inhibition. Surprisingly, we have found that
proteasomes function at relatively the same rate in DF508-
CFTR-expressing cells as in control cells and CFTR-expressing
cells, according to a luciferase assay of proteasome activity
(supplementary Fig. S7A). Yet, supporting our hypothesis, the use
of proteasome inhibitors in control cells or cells expressing wild
type CFTR increases AAV transduction to just over that of
untreated cells expressing DF508-CFTR (see supplementary Fig.
S7B). Treating DF508 cells with proteasome inhibitors results in a
partial increase in transduction that is not as effective as in
control cells (a three-fold increase compared to 10-fold in
controls). These data point to the proteasomal pathway as having
a significant impact on viral transduction in this setting. While it
is tempting to speculate that dysfunction of the ubiquitin/
proteasome system is a primary factor leading to AAV’s ability to
exploit the stressed subcellular environment, our siRNA results
(Fig. 7) suggest that other changes in the secretory pathway are
additionally at play. Together, our findings suggest the increase in
susceptibility to AAV infection in DF508 cells is not strictly due to
a direct inhibition of the proteasome, but could also be due to
saturation or sequestration of pathway components upstream of
catalytic action.
Maintaining homeostasis in the secretory pathway is paramount
for proper folding or disposal of misfolded proteins. Throughout
its biogenesis and degradation, DF508-CFTR interacts with a
multitude of proteins in the cell [65] and may influence the
effectiveness of quality control machinery in the post-ER secretory
pathway. One hypothesis is that during stressed conditions,
expression of DF508-CFTR or other misfolded proteins may
saturate or sequester proteins with chaperone and quality control
function. AAV infection may be enhanced if these proteins would
otherwise impede virus trafficking or processing. Indeed, we have
identified overlapping systems that process DF508-CFTR and
influence AAV. Proteins known to play a role in DF508-CFTR
processing include the chaperones calnexin, Hsp90, and the Hsc-
Hsp40/Hsp70 complexes [4]. In one report, Hsp90 has been
shown to inhibit AAV infection [66], and similarly, we see that the
Hsp90 inhibitor radicicol potently increases transduction (supple-
mentary Fig. S1B), as does siRNA-mediated knockdown of
calnexin (Fig. 7). Although siRNA-mediated knockdown of
calnexin increases AAV transduction in HEK-293 and HeLa
cells, this does not necessitate an interaction between calnexin and
AAV capsids. Loss of calnexin has been shown to be associated
with an increased constitutively active unfolded protein response
[67]. While many viruses have been shown to manipulate the
unfolded protein response during infection, it is unclear whether
this influences AAV transduction. It is noteworthy to mention that
activating or inactivating a major axis of the unfolded protein
response through IRE1/XPB-1, which is linked to ER expansion
and Ca
2+-mediated inflammation in human airway epithelium
[30], did not impact rAAV2 transduction in a human bronchial
epithelial cell line (supplementary Fig. S8). However, we cannot
rule out that other arms of the unfolded protein response (ATF6 or
PERK pathways) could be involved, or that factors in addition to,
and/or superseding an unfolded protein response might be
engaged to mediate increased AAV transduction during subcel-
lular stress.
Interestingly, siRNA-mediated knockdown of HDAC6 or
dynactin did not significantly impact AAV infection under the
conditions tested. These proteins are putatively required for
microtubule-based transport of misfolded proteins like DF508-
CFTR to aggresomes and autophagosomes [68,69]. In agreement
with these siRNA studies, we did not find AAV capsids to
colocalize with cellular markers for aggresomes or autophago-
somes in HeLa cells (vimentin, atg5, atg7, LC3; data not shown).
However, we cannot conclude that AAV infection is unaffected by
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nine, an inhibitor of autophagy to increase AAV-mediated gene
delivery (supplementary Fig. S1B).
The most significant siRNA-mediated effect on AAV infection
in these studies was found with knockdown of PSMB3 (Fig. 7), a
proteasome subunit that has been reported to interact with DF508-
CFTR, but not wild-type CFTR [65]. PSMB3 knockdown
increased the number of GFP-positive cells, but more impressively
augmented expression intensity in both HEK-293 and HeLa cells.
Knocking down KDEL-R or b-COP also modulates AAV
infection efficiency. It is not clear what role these proteins may
play in AAV trafficking, but classically KDEL-R and b-COP are
retrograde transport proteins, which serve as ER-retention devices
for misfolded proteins that transition between the Golgi, ER-
intermediate compartment, and the ER [44]. KDEL-R was
recently identified as a potential AAV capsid binding partner in a
yeast two-hybrid screen [70]. Capsid mutagenesis studies may in
the future shed light on how AAV is recognized by cellular sensors
in the post-ER secretory pathway, and potentially elucidate how
these factors could restrict viral trafficking. Additionally, we’d like
to note that the endocytic and secretory systems in polarized cells
are quite different from that in non-polarized cells. In polarized
airway epithelium, the nucleus is positioned near the basolateral
membrane, whereas the ER and Golgi are oriented sub-apically at
the minus end of microtubules. It is currently unclear whether
AAV traffics differently in polarized and non-polarized cells, and
how this would pertain to viral exploitation of subcellular stress.
Considering that viral exploitation of stress may not be related to a
trafficking block occurring at a specific subcellular location, an
attractive hypothesis is that altered capsid processing underlies
enhanced transduction (such as ubiquitination, phosphorylation,
proteolytic processing, etcetera).
The facets of subcellular stress discussed here, such as
expansion of the ER, changes in the secretory pathway,
activation of the unfolded protein response, and dysfunction of
the ubiquitin/proteasome system, will likely have a profound
effect on a cell’s ability to combat infection. In this report we have
illustrated that the consequences of these subcellular stresses,
elicited by exposure to SMM or the presence of misfolded
proteins, can render cells more susceptible to AAV in cellular
models of CF. Irrespective of whether all of these effects
contribute to pathogenesis in diseased airways, it is clear they
are associated with numerous misfolded protein diseases [71]. In
one instance, it has been shown that adaptation to constitutive
expression of misfolded surfactant protein C, led to increased
susceptibility to RSV infection in vitro [72], corresponding with
enhanced cytotoxicity. It will be of great interest to uncover if
exploitation of subcellular stress by pathogens is a generalized
phenomenon that occurs in prion diseases, Parkinson’s disease (a-
synuclein), amyotrophic lateral sclerosis (superoxide dismutase-1),
hereditary emphysema (a-1-antitrypsin), familial neurohypophy-
seal diabetes insipidus (arginine vasopressin), or many other
disorders that stem from misfolded or unfolded proteins [73].
Even more striking, would be to discover that there is a viral
component to the progression of some of these diseases. If the
presence of misfolded proteins or other subcellular insult, might
render certain cells more susceptible to infection, this parameter
should also hold true for viral-mediated therapies. These may be
important angles to consider as future research shapes new ways
to understand, prevent, and provide treatment for cells under
threat from internal or external stressors.
Materials and Methods
Cell culture
HeLa cells were maintained at 37uC and 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) that was supple-
mented with 10% heat-inactivated fetal calf serum, 100 U/ml
penicillin, and 100 g/ml streptomycin. BHK-21 cells were grown
at 37uC and 5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) and Ham’s F12 medium (50:50) that was supplemented
with 5% heat-inactivated fetal calf serum, 100 U/ml penicillin,
and 100 g/ml streptomycin. BHK-21 clones expressing wild-type
CFTR, CFTR-DF508, CFTR-G551D, CFTR-D572N, CFTR-
1410X, wild-type MRP1, or MRP1-DF728 were maintained in
selection medium containing methotrexate (250 mg/ml). Presence
or absence of methotrexate was not found to influence viral
transduction (data not shown), and selection was continued
throughout the course of infection.
Generation of ciliated HAE in vitro
Human tracheobronchial epithelial cells were isolated fresh
from excess normal surgical specimens from lung transplantation
by the University of North Carolina Cystic Fibrosis Center Tissue
Culture Core under University of North Carolina institutional
review board–approved protocols. As previously described,
primary cells derived from single patient sources were expanded
in tissue culture to generate passage 1 cells, which were plated at a
density of 250,000 cells/cm
2 on permeable membrane support
(Millicells, 12 mm diameter, Millipore, Corning, NY), and
maintained in a specialty media [74]. Cells were differentiated
under air–liquid interface conditions and the cultures were
considered mature after 4–8 weeks when found to be significantly
ciliated (.50% ciliated cells). Experiments were only performed
with fully differentiated HAE cultures.
Virus production
Recombinant AAV or lenti-GFP was produced as described
before in HEK-293 cells [75,76]. RSV packaging GFP was
generated as previously described in HEp-2 cells [77]. Ad type 5
packaging GFP was obtained from the University of North
Carolina Vector Core Facility. Briefly, for production of AAV,
polyethylenimine (linear molecular weight, ,25,000) was used for
triple transfection of the pXR2 cap and rep plasmid, the pXX6-80
helper plasmid, and pTR-Luciferase or TR-GFP reporter
plasmids containing either luciferase or enhanced green fluores-
cent protein (GFP) transgenes flanked by inverted terminal
repeats. At 60 hr post-transfection cells were harvested and virus
purified by cesium chloride gradient density centrifugation for 5 hr
at 65,000 rpm or overnight at 55,000 rpm in an NVT65 rotor
(Beckman). Virus was dialyzed into 16phosphate-buffered saline
(PBS) to remove small molecular weight contaminants from
fractions containing peak viral titers, which were identified by dot
blot hybridization. Titers were calculated by qPCR according to
established procedures [42] using a LightCycler 480 using Sybr
green (Roche) and primers designed against firefly Luciferase (TR-
CBA-Luc) or enhanced green fluorescent protein (TR-CMV-GFP)
transgene.
Collection of SMM and transduction of HAE cultures
Lumenal mucopurulent material from excised human CF lungs
was harvested at the North Carolina Cystic Fibrosis Center as
previously described [8,9,30]. To ensure a homogenous stimulus,
SMM was pooled from several patients. For treatment prior to
infection, SMM (20 ml) was added to the apical surface of fully
differentiated HAE cultures in Millicells for 24 hr. Prior to virus
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were washed two times with PBS. An AAV variant (HAE-2)
previously isolated from directed evolution in HAE cultures [31]
was used in these studies. Approximately 5610
10 particles of
HAE-2 packaging either GFP or Luc were applied to the apical
surface of HAE cultures in PBS for 4 hr. Virus was washed from
the apical surface and GFP or Luc expression was assayed 1 week
post-infection.
Luciferase assay of transduction
At least 4 hr prior to infection, HeLa cells or BHK-21 cells were
plated in 24 well plates at a density of 10
5 cells/well. 24 hr after
inoculation with AAV at the indicated vg/cell numbers, luciferase
activity was measured in accordance with the manufacturer’s
instructions (Promega) and with a Wallac1420 Victor2 automated
plate reader. Error bars represent standard deviations from
samples scored in triplicate. Graphs are representative data sets
from at least three independent assays.
GFP flow cytometry analysis of transduction or
transfection
BHK-21 cells were prepared for infection as stated above and
plated in 24 well plates at a density of 10
5 cells/well. After
infection at the indicated MOI, at 24 or 48 hr cells were
trypsinized (100 ml/well), neutralized with growth media (300 ml)
spun down for 5 min at 500 g, and the cell pellets were
resuspended in 500 ml of 1% paraformaldehyde (prepared fresh
in PBS). At least 50,000 cells were counted by flow cytometry for
each sample, with at least three separate samples recorded for each
condition. Graphs are representative data sets from one of three
independent experiments.
Western blotting
CFTR and MRP1 protein samples were analyzed as previously
described [35]. Briefly, cells were lysed and subjected to SDS-
PAGE gel electrophoresis on 6% polyacrylamide gels. Proteins
were transferred to nitrocellulose membranes and blots were
probed with anti-CFTR monoclonal 596 or monoclonal anti-
MRP1 antibody 897.2 and visualized by enhanced chemilumi-
nescence detection (General Bioscience).
Quantifying genomes by PCR
DNA was isolated from cell samples using DNeasy columns
(Qiagen) according to the manufacturers protocol. Quantitative
PCR was performed on a LightCycler 480 using Sybr green
(Roche) and primers designed against the firefly Luciferase
transgene: (fwd) 59 AAA AGC ACT CTG ATT GAC AAA
TAC 39, and (rev) 59 CCT TCG CTT CAA AAA ATG GAA C
39. Conditions used for the reaction were as follows: 1 cycle at
95uC for 10 min, 45 cycles at 95uC for 10 sec, 62uC for 10 sec,
72uC for 10 sec, 1 cycle at 95uC for 30 sec, 65uC for 1 min, and
99uC for acquisition.
Transfection of BHK-21 cells with reporter plasmids
BHK-21 control cells, CFTR cells, or DF508 cells were plated at
a density of 10
5 cells/well and 4 hr laterweretransfected witheither
TR-CBA-Luc or TR-CMV-GFP reporter plasmids using PEI. For
each well 500 ng DNA was mixed with 5 ml PEI (1 mg/ml)
in 100 ml of serum-free DMEM and incubated at room temp for
10 min before adding the mixture to cell medium. 24 hr after
transfection, cells were harvested for luciferase assays or flow
cytometry analysis of GFP expression as indicated below.
Confocal immunofluorescence microscopy
Similar to what we have previously described [42,78], HeLa
cells or BHK-21 cells (5610
4 cell/well) were plated on poly-L-
lysine-coated 12 mm glass coverslips (#1.5) 4 hr before
infection. AAV2 virions were added to cell media at designated
vector genome amounts. No virus was added to control wells.
After infection, cells were washed three times with PBS and then
fixed with 2% paraformaldehyde for 15 min at room temper-
ature. Cells were then permeabilized with 0.1% Triton X-100 in
PBS for 5 min at room temperature, washed four times with
PBS, and then blocked with immunofluorescence buffer (IFB)
(20 mM Tris, pH 7.5, 137 mM NaCl, 3 mM KCl, 1.5 mM
MgCl2, 5 mg/ml bovine serum albumin, 0.05% Tween) for
30 min at room temperature. The cells were incubated with
primary antibody to detect intact capsids [(monoclonal A20
(1:10)], or cellular markers (anti-c-tubulin (Abcam Ab16504
1:250), anti-BiP (Abcam Ab21685 1:1000), anti-calnexin (Abcam
Ab 13504 1:1000), anti-calreticulin (Abcam Ab2907 1:1000),
anti-KDEL-R (Santa Cruz Biotechnology sc-33806 1:50), anti-b-
COP (Abcam Ab2899 1:1000), or anti-CFTR-570 (1:500)]
diluted in IFB, for 1 hr at 37uC or overnight at 4uC. The cells
were then incubated in secondary antibody, diluted 1:5000 in
IFB (anti-mouse Alexa Fluor 488; or anti-rabbit Alexa Fluor
568, anti-mouse IgG3 Alexa Fluor 488, or anti-rabbit IgG1a
Alexa Fluor 568, Molecular Probes), for 1 hr at 37uC. After
six washes in PBS, coverslips were mounted cell side down on
glass slides with mounting medium (Prolong antifade Gold with
DAPI [49,69-diamidino-2-phenylindole]; Molecular Probes). Im-
ages were captured on a Leica SP2 AOBS upright laser
scanning confocal microscope and processed for brightness or
contrast using Photoshop CS4 (Adobe). Confocal Z-stack
sections of BHK-21 cells for immunofluorescence localization
of AAV2 capsids and CFTR or DF508-CFTR protein were
processed and rendered in 3-dimensions using Volocity software
(Improvision).
siRNA transfection
Specific knockdown of secretory pathway components or factors
that process misfolded proteins was obtained by double transfec-
tion of siRNA (Qiagen, Flexitube) using Hiperfect (Qiagen)
according to the manufacturer’s protocol for fast-forward
transfection of adherent cells. Briefly, 200,000 HEK-293 cells or
70,000 HeLa cells were plated into 24 well plates and mixed
immediately with pre-incubated DMEM, transfection reagent, and
siRNA at a final concentration of 10 nM. After verifying
knockdown, approximately two days post-transfection cells were
trypsinized and replated at equal densities for transduction assays
using either AAV2-GFP or HIV-GFP. Knockdown was verified by
analyzing protein levels by western blot or by quantifying mRNA
from transfected cells compared to controls by using SuperScript
III CellsDirect cDNA Synthesis Kit (Invitrogen) according to the
manufacturer’s instructions, and subsequently testing samples by
qPCR. Target accession numbers were as follows: BiP - NM_
005347; calnexin - NM_001746; calreticulin - NM_004343;
KDEL-R3 - NM_006855; b-COP - NM_001144061; HDAC6 -
NM_006044; dynactin4 - NM_016221; PSMB3 - NM_002795.
Catalogue numbers for the paired siRNAs were as follows: BiP –
SI02780554, SI02781016; calnexin – SI02663367, SI02757300;
calreticulin – SI02654589, SI02777096; KDEL-R3 –SI02638181,
SI03100580; b-COP – SI00299887, SI04141438; HDAC6 -
SI02663808, SI02757769; dynactin4 – SI00360444, SI00360437;
PSMB3 – SI02654239, SI02653882.
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For studies involving quantification of luciferase or GFP
expression a one-way analysis of variance (ANOVA) was used to
determine if a statistical difference existed between mean values. If
any of the means differed, a Tukey HSD test was performed to
determine p-values for sample means that differed from control
BHK-21 cells and BHK-21 cells expressing wild-type CFTR. A p-
value#0.05 was considered significant and marked in the figures
as (*). A p-value#0.01 is marked (**). All data were analyzed using
Excel software (Microsoft).
Accession numbers
For information on cystic fibrosis (CF) please see Online
Mendelian Inheritance in Man database (MIM) #219700. The
CFTR protein can be referenced through GeneID: 1080, and
CFTR mutations in association with disease through MIM:
602421. The viruses discussed in the manuscript text have the
following accession numbers: adeno associated virus - Refseq:
NC_001401, Taxonomy ID: 10804; adenovirus - Refseq:
AC_000008, Taxonomy ID: 28285; respiratory syncytial virus -
Taxonomy ID: 11250. Proteins targeted for the siRNA studies
included the following: BiP - GeneID: 3309; calnexin - GeneID:
821; calreticulin - GeneID: 811; KDEL-R - GeneID: 11015; b-
COP - GeneID: 1315; Dynactin - GeneID: 479326; HDAC6 -
GeneID: 10013; and PSMB3 - GeneID: 5691.
Supporting Information
Figure S1 Exploitation during infection likely occurs between
virus binding and gene expression. A. Cell surface binding of
AAV2. Equal numbers of control wt BHK-21 cells (purple
diamonds), cells expressing CFTR (red squares), or DF508-CFTR
(blue triangles) seeded in 24 well plates were cooled to 4uCt o
inhibit endocytosis. AAV2 was applied (10,000 vg/cell) for the
indicated times, and the DNA was harvested for qPCR
quantification of vector genomes. Error bars represent standard
deviations from three independent samples. B. Analysis of
expression levels after transfection of reporter plasmids by flow
cytometry indicating mean fluorescence intensity (MFI) of GFP-
positive cells 24 hr after transfection of TR-eGFP in control cells,
cells expressing CFTR, or DF508-CFTR C. Luciferase assay of
reporter expression in control cells, CFTR-expressing cells, or
DF508-CFTR expressing cells, 24 hr after transfection with a TR-
Luc plasmid. Error bars represent standard deviations from three
samples.
(TIF)
Figure S2 Subcellular stress pathways in trafficking and
transduction. A. Confocal immunofluorescence microscopy de-
picts AAV2 capsids (i, green) trafficking near the microtubule
organizing center (ii - c-tubulin, red) at 4 hr post-infection in HeLa
cells. B. Luciferase assay of transduction showing several
treatments that influence misfolded protein processing positively
impact AAV2 transduction. AAV2 capsids (10,000 vg/cell) were
administered concurrently with either vehicle controls (DMSO or
EtOH), or ALLN (40 mM), MG132 (2 mM), Radicicol (10 mM), 3-
methyladenine (10 mM), or administered directly after treating
with L-canavanine (10 mM, 12 hr), or during heat shock (4 hr at
42.5uC). DMSO and EtOH did not significantly influence
expression. The proteasome inhibitors ALLN and MG132
increased transduction between 30 and 40-fold. The Hsp90
inhibitor, radicicol, known to perturb chaperone activity and
induce a heatshock-like response [79], increased transduction by
roughly 100-fold. 3-methyladenine, an inhibitor of autophagy
[80,81], augmented transduction by at least 20-fold. L-canavan-
ine, an amino acid analogue of arginine, induces widespread
protein misfolding [82] and increased AAV transduction 5- to 10-
fold. Heat shock also increased transduction as previously
documented [51]. Luciferase activity was measured 24 hr
post-infection.
(TIF)
Figure S3 siRNA-mediated knockdown of secretory pathway
components or proteins involved in CFTR processing. A.
Representative Western blots demonstrating levels of target
protein reduction compared to GAPDH or b-actin controls after
siRNA transfection (,48 hr), corresponding to time of infection.
B. For those targets where a reliable antibody was not available for
Western blot (KDEL-R and PSMB3), we quantified levels of
mRNA by RT-qPCR, normalized to mRNA for GAPDH.
Transfections for mock conditions (transfection reagent alone),
control (non-targeted siRNA), or two target siRNAs were
performed in HEK-293 and HeLa cells according to procedures
described in Materials and Methods.
(TIF)
Figure S4 Chymotrypsin-like proteasome activity in cells
transfected with siRNA. Two days following transfection with
non-targeted control or indicated targeted siRNAs, HEK-293 (A)
or HeLa cells (B) were split to 20,000 cells/well in 96 well plates
and tested for proteasome activity using a cell-based luciferase
assay (Promega G8660) according to the manufacturer’s instruc-
tions. Data shown are representative of two experiments with
standard deviations from three independent samples.
(TIF)
Figure S5 Quantification of viral uptake in cells transfected with
siRNA. Between 36 and 48 hr following transfection with non-
targeted control or indicated targeted siRNAs, HEK-293 (A) or
HeLa cells (B) were inoculated with rAAV2 (5,000 vg/cell or
10,000 vg/cell, respectively) for 24 hr. Total DNA was harvested
from cells by DNeasy preparation according to procedures in
Materials and Methods and viral genomes were quantified by
qPCR which were normalized to GAPDH levels. Data shown
represent averages with standard deviations from two independent
experiments.
(TIF)
Figure S6 Transduction efficiency of self-complementary
rAAV2 in cells transfected with siRNA. Transduction efficiency
of self-complementary AAV2 (scAAV2) following siRNA-medi-
ated knockdown of proteins in HEK-293 cells (A) or HeLa cells
(B). A margin of error for nonsignificant perturbations of
infection (roughly 630% relative to controls) is indicated by
dashed lines. Cells were mock transfected or transfected
with non-targeting control siRNA, or siRNA targeting BiP,
calnexin, calreticulin, KDEL-R, b-COP, HDAC6, dynactin, or
PSMB3. Between 36 and 48 hr after transfection, cells were
infected with scAAV2-GFP (50 vg/cell, HEK-293; 100 vg/cell,
HeLa) and fixed for flow cytometry 24 hr post-infection. Data is
reported as the percentage of cells infected times mean
fluorescence intensity. Data is representative of two independent
experiments with error bars indicating standard deviation.
Samples that were statistically different from controls are
marked (*p,0.05).
(TIF)
Figure S7 Influence of the ubiquitin/proteasome system on
AAV infection in models of CF. A. Luciferase assay of proteasome
activity in BHK-21 cells with or without proteasome inhibitor
(MG132, 2 mM). B. Luciferase assay of AAV2 transduction in
HEK-293 cells with or without proteasome inhibitor. AAV2
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control, CFTR, or DF508 cells in 24 well plates and scored for
transduction 24 hr after inoculation. Proteasome inhibition
potentiates infection efficiency in each cell type, but is less effective
in DF508 cells.
(TIF)
Figure S8 Influence of XBP-1 splicing and the unfolded protein
response on rAAV2 transduction. Transformed human bronchial
epithelial cells (16HBE14o-, control), or 16HBE14o- cells stably
expressing dominant negative XBP-1 (DN-XBP-1), or expressing
constitutively active XBP-1 [spliced XBP-1; (Lee, A. H., Iwakoshi,
N. N., and Glimcher, L. H. (2003.) Mol. Cell. Biol. 23 7448–
7459)], were inoculated with rAAV2 at the indicated particle
numbers. After 24 hr a luciferase assay of transduction was
performed to measure efficiency of AAV2-mediated gene delivery.
Error bars represent standard deviations from four independent
samples.
(TIF)
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